INVESTIGATION OF INFLAMMATION ASSOCIATED CYP2E1 AND CYP1A1 EXPRESSION IN THE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS MOUSE MODEL OF MULTIPLE SCLEROSIS

2023-1-27
Solak, Damla
Multiple sclerosis (MS) is an autoimmune neurodegenerative disease which affects brain and spinal cord. Myelin which wraps around the axon and its progenitor cells, oligodendrocytes, are destroyed in this disease. This results in the loss of signal transmission which leads to axonal, and eventually neuronal loss. There are various symptoms of the disease such as unstable feelings, fatigue, visual disability, muscle spasms, and walking difficulties. The etiology of the disease is still in its infancy; however, genetic, environmental factors, and abnormal immune responses are known to play a role in the development of multiple sclerosis. Cytochrome P450, one of the members of monooxygenases, are the enzymes predominantly localized in the liver but also in lung, brain, and kidney. They have an essential role in the metabolism of drugs, other xenobiotics, and endogenous substrates and activation of the procarcinogens. CYP2E1 is the second highly expressed CYP450 enzyme in liver and is also found in brain. CYP1A1 is mainly localized in lung but also in the brain and liver. The expression of CYP450 enzymes varies under inflammatory conditions. Accordingly, the bioavailability of drugs and other exogenous and endogenous substrates that are metabolized by these enzymes will be equally affected. Therefore, as multiple sclerosis is an inflammatory neurodegenerative disorder, unique expression levels of these enzymes need to be examined in these conditions. The possible change in gene (mRNA) and protein expression of CYP2E1 and CYP1A1 enzymes in liver and brain in the case of MS has not been investigated before. In this study, female C57BL/6 mouse model for experimental autoimmune encephalomyelitis (EAE - MS Model) was used to investigate the effects of EAE on mRNA and protein levels of CYP2E1 and CYP1A1 by qPCR and Western blotting techniques, respectively. The mRNA and the protein expression of the control group were equilibrated to 1.00 fold and the relative expression of the EAE group were estimated. The results of this study illustrate that the EAE immunization was not significantly affecting the mRNA and the protein levels of CYP2E1 and CYP1A1 in mice liver and brain. Nevertheless, protein expression of CYP2E1 is slightly higher in the EAE group compared to the control group. Moreover, CYP2E1 and CYP1A1 mRNA expressions were increased slightly in the liver of the EAE group and CYP2E1 mRNA expression was decreased slightly in the brain of EAE group compared to the control group, but the results were not statistically significant.

Suggestions

Investigation of Glutathione S-Transferase (GST) expression and activity in mouse with Multiple Sclerosis (MS)
Arçak, Deniz; Adalı, Orhan; Evin, Emre; Department of Biology (2022-5-11)
Multiple Sclerosis (MS) of unknown etiopathogenesis is a chronic demyelinating disease of the central nervous system. It mainly destroys myelin in the brain and spinal cord. Non-traumatic injuries have been observed in this disease for young adults. Various factors affect MS, but oxidative stress is one of the most important causes of demyelination. Glutathione S- Transferases (GSTs) can be described as a versatile enzyme family of eukaryotic and prokaryotic phase II metabolic isoenzymes. They have enzymati...
INVESTIGATION OF EFFECTS OF VITAMIN D AND VITAMIN D METABOLIZING CYP450 ISOZYMES ON MULTIPLE SCLEROSIS PATHOPHYSIOLOGY IN ANIMAL MODEL BY MOLECULAR APPROACHES
Evin, Emre; Adalı, Orhan; Department of Biology (2021-8)
Multiple sclerosis (MS) is a complicated, recurrent, and often progressive inflammatory demyelinating autoimmune disease of the central nervous system, yet etiopathogenesis remains unsolved. MS frequency increases with increasing latitude, leading to a hypothesis that MS is inversely correlated with the duration and intensity of sunlight and vitamin D concentrations. In this study, the relationships between vitamin D supplementation, MS, VDR, and vitamin D metabolizing CYP enzymes, including CYP2R1, CYP27A1...
Analyzing the expression patterns of vitamin D metabolizing CYP27B1 and CYP24A1 in brain tissue of vitamin D treated mice with Multiple Sclerosis (MS)
Özdoğan, Dilara; Adalı, Orhan; Evin, Emre; Department of Molecular Biology and Genetics (2022-8)
The etiopathogenesis of Multiple Sclerosis (MS), an inflammatory demyelinating autoimmune disease of the central nervous system, is still unknown. MS is a complex, recurring, and frequently progressing condition. There is a hypothesis that MS is adversely associated with the length and intensity of sunlight exposure and vitamin D concentrations since MS frequency rises with increasing latitude. A female C57BL/6 mouse model for autoimmune encephalomyelitis (EAE) was used in this investigation to examine the ...
Generation and Characterization of Induced Pluripotent Stem Cell Lines From Multiple Sclerosis Patients and Healthy Individuals
Begentaş, Onur Can; Kiriş, Erkan; Department of Molecular Biology and Genetics (2021-9-8)
Multiple Sclerosis (MS) is an autoimmune disease characterized by inflammation, demyelination, and axonal damage resulting in neurodegeneration in the central nervous system (CNS). Relapsing-remitting MS (RRMS) is the most common form of the disease known to affect more than 2 million individuals globally, and the prevalence of the disease is increasing worldwide. As a chronic condition without a cure, RRMS manifests in a relapsing-remitting form with sporadic attacks suddenly appearing, causing neurologica...
Generation and characterization of human induced pluripotent stem cell line METUi001-A from a 25-year-old male patient with relapsing-remitting multiple sclerosis
Koc, Dilara; Begentaş, Onur Can; Yurtogullari, Sukran; Temel, Musa; Akcali, Kamil Can; Demirkaya, Seref; Kiriş, Erkan (2021-05-01)
Multiple sclerosis is a chronic disease characterized by inflammation, demyelination, and axonal damage in the central nervous system. Here, we established an induced pluripotent stem cell (iPSC) line METUi001-A from the peripheral blood mononuclear cells of a 25-year-old male individual with clinically diagnosed Relapsing-Remitting Multiple Sclerosis (RRMS) using the integration-free Sendai reprogramming method. We demonstrated that the iPSCs are free of exogenous Sendai reprogramming vectors, have a norma...
Citation Formats
D. Solak, “INVESTIGATION OF INFLAMMATION ASSOCIATED CYP2E1 AND CYP1A1 EXPRESSION IN THE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS MOUSE MODEL OF MULTIPLE SCLEROSIS,” M.S. - Master of Science, Middle East Technical University, 2023.